주식/증권
📈 긍정적
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?
요약
GoodRx has had an impressive run over the past six months as its shares have beaten the S&P 500 by 13.1%. The stock now trades at $3.14, marking a 21.5% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.